Estados financieros detallados de Precision Optics Corporation, Inc. (POCI): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Precision Optics Corporation, Inc. registró ingresos de $19.1M en el último ejercicio fiscal, con un CAGR de 5 años del 14.0%.
Márgenes de los últimos 12 meses: margen bruto 13.8%, margen operativo -16.4%, margen neto -17.0%.
Al precio actual de $4.17, POCI presenta beneficios negativos (P/E no significativo) y un ROE del -37.47%. La capitalización bursátil es de $46M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $3.9M | $3.2M | $4.0M | $6.8M | $9.9M | $10.7M | $15.7M | $21.0M | $19.1M | $19.1M |
| Coste de Ventas | $3.0M | $2.4M | $2.6M | $4.7M | $6.6M | $7.2M | $10.8M | $13.3M | $13.3M | $15.7M |
| Beneficio Bruto | $942021 | $773724 | $1.5M | $2.1M | $3.4M | $3.4M | $4.9M | $7.7M | $5.8M | $3.4M |
| I+D | $478267 | $464162 | $456377 | $505300 | $886129 | $624253 | $666479 | $992375 | $981781 | $1.2M |
| Generales y Administrativos | $1.6M | $1.3M | $1.4M | $2.1M | $3.9M | $3.7M | $5.6M | $7.4M | $7.5M | $7.8M |
| Gastos Operativos | $2.0M | $1.8M | $1.8M | $2.6M | $4.8M | $4.3M | $6.3M | $8.4M | $8.5M | $9.0M |
| Beneficio Operativo | -$1.1M | -$1.0M | -$348619 | -$612543 | -$1.4M | -$905583 | -$1.4M | -$638548 | -$2.7M | -$5.6M |
| EBITDA | -$1.0M | -$968736 | -$321403 | -$573989 | -$1.3M | $50177 | -$526568 | $286985 | -$2.5M | -$5.3M |
| Gastos por Intereses | $469 | $3144 | $1859 | $1416 | $1000 | $5302 | $155658 | $218927 | $225108 | $227019 |
| Beneficio Antes de Impuestos | -$1.0M | -$1.0M | -$350478 | -$613959 | -$1.4M | -$101923 | -$927464 | -$142677 | -$2.9M | -$5.8M |
| Impuestos | $912 | $912 | $912 | $912 | $2165 | $912 | $952 | $1936 | $1936 | $1936 |
| Beneficio Neto | -$1.0M | -$1.0M | -$351390 | -$614871 | -$1.4M | -$102835 | -$928416 | -$144613 | -$3.0M | -$5.8M |
| BPA | $-0.45 | $-0.36 | $-0.11 | $-0.16 | $-0.33 | $-0.02 | $-0.18 | $-0.03 | $-0.49 | $-0.85 |
| BPA Diluido | $-0.43 | $-0.36 | $-0.11 | $-0.16 | $-0.33 | $-0.02 | $-0.18 | $-0.03 | $-0.49 | $-0.85 |
| Acciones en Circulación (Diluidas) | $2.4M | $2.8M | $3.3M | $3.8M | $4.3M | $4.4M | $5.3M | $5.7M | $6.1M | $6.8M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $50059 | $118405 | $402738 | $2.3M | $1.1M | $861650 | $605749 | $2.9M | $405278 | $1.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $750380 | $468548 | $796923 | $2.2M | $1.5M | $1.9M | $2.7M | $3.9M | $3.5M | $4.3M |
| Inventario | $1.1M | $1.1M | $1.1M | $1.7M | $2.2M | $1.9M | $3.0M | $2.8M | $2.9M | $3.6M |
| Activos Corrientes | $2.0M | $1.7M | $2.4M | $6.4M | $4.9M | $4.8M | $6.5M | $9.9M | $7.1M | $10.1M |
| Inmovilizado Material | $78195 | $72254 | $49486 | $383006 | $621553 | $655499 | $1.1M | $791957 | $683572 | $675617 |
| Fondo de Comercio | 0 | 0 | 0 | $687664 | $687664 | $687664 | $8.8M | $8.8M | $8.8M | $8.8M |
| Activos Intangibles | $22874 | $30086 | $47275 | $54087 | $95229 | $141702 | $229398 | $265111 | $286559 | $232493 |
| Activos Totales | $2.1M | $1.8M | $2.5M | $7.5M | $6.4M | $6.3M | $16.7M | $19.7M | $16.9M | $19.8M |
| Cuentas por Pagar | $1.2M | $694958 | $703538 | $1.2M | $1.1M | $1.2M | $2.2M | $2.4M | $1.4M | $2.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $808962 | 0 | $367714 | $513259 | $1.3M | $577898 |
| Pasivos Corrientes | $1.5M | $1.2M | $1.9M | $3.6M | $3.1M | $2.5M | $4.6M | $5.3M | $4.9M | $6.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $2.0M | $2.2M | $1.9M | $1.3M |
| Pasivos Totales | $1.5M | $1.2M | $1.9M | $4.1M | $3.6M | $2.8M | $7.7M | $7.7M | $6.8M | $7.5M |
| Reservas | -$43.7M | -$44.7M | -$45.0M | -$45.6M | -$47.1M | -$47.2M | -$48.1M | -$48.2M | -$51.2M | -$57.0M |
| Patrimonio Neto | $587172 | $558380 | $564036 | $3.4M | $2.8M | $3.4M | $9.0M | $12.0M | $10.1M | $12.3M |
| Deuda Total | $39812 | $31955 | $23563 | $14599 | $1.0M | $251991 | $3.0M | $3.2M | $3.4M | $2.0M |
| Deuda Neta | -$10247 | -$86450 | -$379175 | -$2.3M | -$119761 | -$609659 | $2.4M | $233515 | $3.0M | $262685 |
| Capital Circulante | $518058 | $479604 | $481876 | $2.8M | $1.8M | $2.3M | $1.9M | $4.6M | $2.2M | $3.9M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$1.0M | -$1.0M | -$351390 | -$614871 | -$1.4M | -$102835 | -$928416 | -$144613 | -$3.0M | -$5.8M |
| Amortizaciones | $25856 | $33660 | $27216 | $38554 | $112219 | $146799 | $190221 | $210735 | $212382 | $212439 |
| Compensación en Acciones | $241388 | $201612 | $52341 | $473326 | $502345 | $733930 | $915494 | $919032 | $959784 | $1.5M |
| Cambio en Capital Circulante | -$117020 | $71366 | $142590 | -$936785 | $172597 | $74685 | -$423603 | -$364439 | -$921305 | $513431 |
| Flujo de Caja Operativo | -$876298 | -$667434 | $100657 | -$1.0M | -$592492 | $46550 | -$933371 | -$81090 | -$2.7M | -$3.5M |
| Inversiones (CapEx) | -$8602 | -$34931 | -$21637 | -$146850 | -$160292 | -$122397 | -$152740 | -$52497 | -$293883 | -$227209 |
| Adquisiciones | $32707 | $1515 | 0 | $106545 | -$1.4M | -$166667 | -$255062 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$884900 | -$702365 | $79020 | -$1.2M | -$752784 | -$75847 | -$1.1M | -$133587 | -$3.0M | -$3.8M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -19.5% | +28.0% | +68.5% | +45.8% | +7.6% | +46.9% | +34.2% | -9.2% | -0.1% | |
| Crecimiento Beneficio Neto (anual) | +2.7% | +65.1% | -75.0% | -131.9% | +92.8% | -802.8% | +84.4% | -1940.9% | -95.8% | |
| Crecimiento BPA (anual) | +20.0% | +69.4% | -45.5% | -106.2% | +93.0% | -675.9% | +85.8% | -1821.6% | -73.5% | |
| Cambio en Acciones (anual) | +16.6% | +17.8% | +16.9% | +13.2% | +2.2% | +19.6% | +7.0% | +7.1% | +11.9% | |
| Crecimiento FCF (anual) | +20.6% | +111.3% | -1591.4% | +36.1% | +89.9% | -1332.0% | +87.7% | -2128.4% | -26.8% | |
| Margen Bruto | 24.1% | 24.5% | 36.7% | 31.2% | 33.9% | 32.2% | 31.4% | 36.8% | 30.3% | 17.8% |
| Margen Operativo | -26.9% | -31.8% | -8.6% | -9.0% | -14.3% | -8.5% | -8.6% | -3.0% | -14.3% | -29.1% |
| Margen EBITDA | -25.7% | -30.7% | -8.0% | -8.4% | -13.2% | 0.5% | -3.4% | 1.4% | -13.1% | -28.0% |
| Margen Neto | -26.4% | -31.9% | -8.7% | -9.0% | -14.4% | -1.0% | -5.9% | -0.7% | -15.4% | -30.3% |
| Margen FCF | -22.6% | -22.3% | 2.0% | -17.3% | -7.6% | -0.7% | -6.9% | -0.6% | -15.6% | -19.8% |
| Tasa Impositiva Efectiva | -0.1% | -0.1% | -0.3% | -0.1% | -0.2% | -0.9% | -0.1% | -1.4% | -0.1% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.37 | $-0.25 | $0.02 | $-0.31 | $-0.17 | $-0.02 | $-0.21 | $-0.02 | $-0.49 | $-0.56 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $2.3M | $2.8M | $3.3M | $3.8M | $4.3M | $4.4M | $5.3M | $5.7M | $6.1M | $6.8M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -37.47% |
| Rentabilidad sobre capital invertido | -19.51% |
| Rentabilidad sobre activos | -14.63% |
| Margen bruto | 13.85% |
| Margen operativo | -16.44% |
| Margen neto | -17.03% |
Salud financiera
| Deuda / Patrimonio | 0.21 |
| Ratio corriente | 2.10 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -1.10 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -3.53 | -5.00 | -14.45 | -21.38 | -13.18 | -217.24 | -33.17 | -241.18 | -12.71 | -5.76 |
| P/VC | 6.23 | 8.97 | 9.23 | 3.88 | 6.80 | 6.50 | 3.52 | 2.89 | 3.76 | 2.71 |
| P/V | 0.93 | 1.59 | 1.29 | 1.92 | 1.90 | 2.09 | 2.02 | 1.66 | 1.98 | 1.74 |
| Margen Bruto | 24.1% | 24.5% | 36.7% | 31.2% | 33.9% | 32.2% | 31.4% | 36.8% | 30.3% | 17.8% |
| Margen Operativo | -26.9% | -31.8% | -8.6% | -9.0% | -14.3% | -8.5% | -8.6% | -3.0% | -14.3% | -29.1% |
| Margen Neto | -26.4% | -31.9% | -8.7% | -9.0% | -14.4% | -1.0% | -5.9% | -0.7% | -15.4% | -30.3% |
Empresas relacionadas: APUS · HBIO · IGC · MIRA · MLSS · MODD · MYO
Explorar sector: Healthcare · Medical - Instruments & Supplies
Más secciones de POCI: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones